View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
July 6, 2020

UK invests £8.4m in study of long-term impact of Covid-19

By Allie Nawrat

UK Research and Innovation (UKRI) and the UK’s National Institute of Health Research (NIHR) have granted £8.4m in research funding to a large study of the physical and mental health impacts of Covid-19 on hospitalised patients.

This study, called the Post-HOSPitalisation COVID-19 (PHOSP-COVID) trial, aims to recruit around 10,000 patients to inform better treatment and rehabilitation of hospitalised patients. It is being coordinated by NIHR Leicester Biomedical Research Centre, but it will be nationwide and involve a consortium of researchers and doctors.

NIHR head and the UK’s chief medical officer Professor Chris Whitty said: “As well as the immediate health impacts of the virus it is also important to look at the longer-term impacts on health, which may be significant.

“We have rightly focused on mortality, and what the UK can do straight away to protect lives, but we should also look at how Covid-19 impacts on the health of people after they have recovered from the immediate disease.

“This UKRI and NIHR funded study is one of the first steps in doing this.”

Related Companies

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy